Driving T-Cell Immunotherapy To Solid Tumors

Driving T-Cell Immunotherapy To Solid Tumors

Image of T-Cell.  T cell receptor (TCR) gene therapy can target the immune system to solid tumors in ways CAR-T cells can’t match, but the field is still looking for a clear success. Last September, GlaxoSmithKline took over one of Adaptimmune Therapeutics’...